Infliximab Shows Favorable Initial Efficacy, But Drug Survival Diminishes in Psoriasis, PsA
Survival and discontinuation rates of infliximab when treating psoriasis in real world conditions were analyzed.
Home
Upadacitinib Superior to Abatacept for RA Refractory to DMARDs
Upadacitinib is superior to abatacept for patients with rheumatoid arthritis refractory to biologic DMARDs.
Time to Results Faster With Point-of-Care COVID-19 Testing
Time to results significantly shorter with QIAstat-Dx Respiratory SARS-CoV-2 Panel than with PCR
Assessing the Importance of Placebo Response in Objective and Subjective Outcomes in RA Clinical Trials
Researchers assessed whether subjective and objective outcomes differed with placebo response in rheumatoid arthritis.
Quantitative MRI and Strength Testing May Detect Muscle Changes in Rheumatoid Arthritis
Researchers assessed whether quantitative MRI can detect differences in the muscles between patients with rheumatoid arthritis and healthy control participants.
Low-Dose Glucocorticoids Increase Risk for Serious Infection in Rheumatoid Arthritis
Continued use of glucocorticoids was associated with dose-dependent increase in the risk for serious infection, with small but significant risk for infection at low doses of 5 mg or less per day.
Case Study Reports First Known Case of Neutrophilic Arterial Vasculitis in COVID-19
Authors of this case study reported the first case of neutrophilic arterial vasculitis in COVID-19.
Examining National Trends in Opioid Use Disorder Hospitalizations in Common Musculoskeletal Diseases
Researchers evaluated opioid use disorder hospitalizations and associated healthcare utilization outcomes in patients with common musculoskeletal diseases.
NIH: Study Will Identify Most Promising Therapies for COVID-19
The NIAID has launched a new study aimed at accelerating the most promising therapies in the fight against coronavirus disease 2019.
Pharmacologic Management of Type 2 Diabetes May Improve Concurrent Polymyalgia Rheumatica Symptoms
The study authors’ goal was to raise the possibility that some patients with polymyalgia rheumatica and type 2 diabetes mellitus can avoid glucocorticoid treatment.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in General Rheumatology
